-
Fund Dashboard
- Holdings
Pharmaceuticals
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
HSBC SECURITIES USA INC | 141.00 k | 141.00 k principal | 4.86 | Repurchase agreement | Long | USA |
SOCIETE GENERALE | 121.00 k | 121.00 k principal | 4.17 | Repurchase agreement | Long | USA |
NATWEST MARKETS PLC | 108.00 k | 108.00 k principal | 3.72 | Repurchase agreement | Long | USA |
CORT Corcept Therapeutics Incorporated | 103.52 k | 2.11 k shares | 3.57 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 96.21 k | 1.61 k shares | 3.31 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 91.46 k | 1.64 k shares | 3.15 | Common equity | Long | USA |
UMB FINANCIAL CORP | 91.00 k | 91.00 k principal | 3.13 | Repurchase agreement | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 90.60 k | 1.07 k shares | 3.12 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 81.64 k | 2.43 k shares | 2.81 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 81.53 k | 741.00 shares | 2.81 | Common equity | Long | Ireland |
VTRS Viatris Inc. | 80.19 k | 6.91 k shares | 2.76 | Common equity | Long | USA |
CTLT Catalent, Inc. | 79.11 k | 1.35 k shares | 2.72 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 78.49 k | 2.91 k shares | 2.70 | Common equity | Long | UK |
PFE Pfizer Inc. | 77.94 k | 2.75 k shares | 2.68 | Common equity | Long | USA |
JNJ Johnson & Johnson | 77.85 k | 487.00 shares | 2.68 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 76.57 k | 860.00 shares | 2.64 | Common equity | Long | USA |
ZTS Zoetis Inc. | 75.62 k | 423.00 shares | 2.60 | Common equity | Long | USA |
PRGO Perrigo Company plc | 74.46 k | 2.91 k shares | 2.56 | Common equity | Long | Ireland |
OGN Organon & Co. | 73.96 k | 3.94 k shares | 2.55 | Common equity | Long | USA |
LLY Eli Lilly and Company | 72.19 k | 87.00 shares | 2.49 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 71.11 k | 695.00 shares | 2.45 | Common equity | Long | USA |
ELAN Elanco Animal Health Incorporated | 70.42 k | 5.57 k shares | 2.43 | Common equity | Long | USA |
CREDIT AGRICOLE CIB NY | 67.00 k | 67.00 k principal | 2.31 | Repurchase agreement | Long | USA |
ARVN Arvinas, Inc. | 62.61 k | 2.37 k shares | 2.16 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 62.55 k | 1.41 k shares | 2.15 | Common equity | Long | USA |
SAVA Cassava Sciences, Inc. | 59.20 k | 2.29 k shares | 2.04 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 58.26 k | 58.26 k shares | 2.01 | Short-term investment vehicle | N/A | USA |
ROYAL BANK OF CANADA | 54.00 k | 54.00 k principal | 1.86 | Repurchase agreement | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 53.01 k | 1.05 k shares | 1.83 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc. | 51.92 k | 704.00 shares | 1.79 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 47.39 k | 1.39 k shares | 1.63 | Common equity | Long | USA |
PCRX Pacira BioSciences, Inc. | 45.28 k | 2.73 k shares | 1.56 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 39.02 k | 1.14 k shares | 1.34 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 37.95 k | 359.00 shares | 1.31 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 35.67 k | 3.39 k shares | 1.23 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals, Inc. | 35.09 k | 613.00 shares | 1.21 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals, Inc. | 29.32 k | 3.46 k shares | 1.01 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 28.75 k | 638.00 shares | 0.99 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 27.76 k | 864.00 shares | 0.96 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 25.02 k | 1.83 k shares | 0.86 | Common equity | Long | Singapore |
EYPT EyePoint Pharmaceuticals, Inc. | 24.74 k | 2.10 k shares | 0.85 | Common equity | Long | USA |
INVA Innoviva, Inc. | 23.26 k | 1.19 k shares | 0.80 | Common equity | Long | USA |
Liquidia Corporation | 22.59 k | 2.08 k shares | 0.78 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 22.19 k | 1.58 k shares | 0.76 | Common equity | Long | USA |
MNMD Mind Medicine (MindMed) Inc. | 21.60 k | 3.43 k shares | 0.74 | Common equity | Long | Canada |
PHAT Phathom Pharmaceuticals, Inc. | 21.40 k | 1.25 k shares | 0.74 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 18.79 k | 5.95 k shares | 0.65 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 18.42 k | 1.61 k shares | 0.63 | Common equity | Long | USA |
EOLS Evolus, Inc. | 16.86 k | 1.03 k shares | 0.58 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 16.77 k | 602.00 shares | 0.58 | Common equity | Long | USA |
Xeris Pharmaceuticals Inc | 11.31 k | 3.51 k shares | 0.39 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 10.82 k | 4.90 k shares | 0.37 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
UBS SECURITIES LLC
|
-7.10 k | 235.00 other units | -0.24 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX
GOLDMAN SACHS GROUP, INC
|
-8.51 k | 186.00 other units | -0.29 | Equity derivative | N/A | USA |